The Latin America, Middle East and Africa Allergy Diagnostics Market would witness market growth of 17.5% CAGR during the forecast period (2022-2028).
Paired with a physical examination and a review of the medical history, allergy testing—which can be done on the skin or through blood can disclose information about both the substances to which people are and are not allergic. A suspected allergenic is scratched into the skin's surface during a skin test to look for a potential reaction that might appear minutes after contact.
Blood testing is advised for those who cannot have skin tests. The blood test will gauge the body's potential production of immunoglobulin E, a type of antibody, in response to allergens. Even though allergic reactions are frequently not dangerous, they might worsen with time. When such reactions occur, people frequently have milder symptoms. They are unaware that these are the reasons why some meals can provoke an allergic reaction. Food allergens can trigger allergic reactions when they come into touch with the immune system.
The healthcare and life sciences industries in the UAE offer numerous prospects for American exporters. The UAE boasts a robust healthcare infrastructure as one of the Middle East's most economically advanced and diverse marketplaces. The government of the UAE has made building a top-notch healthcare infrastructure a primary priority, and as a result, the industry has developed and grown tremendously over the past few years.
The Brazil market dominated the LAMEA Allergy Diagnostics Market by Country in 2021; thereby, achieving a market value of $190.2 million by 2028. The Argentina market is estimated to grow a CAGR of 18.1% during (2022 - 2028). Additionally, The UAE market would experience a CAGR of 17.1% during (2022 - 2028).
Based on End-user, the market is segmented into Diagnostic Laboratories, Academic Research Institutes, Hospital-based Laboratories, and Others. Based on Allergen, the market is segmented into Inhaled, Drug, Food, and Others. Based on Test Type, the market is segmented into In Vivo and In Vitro. Based on Product & Services, the market is segmented into Consumables, Instruments, and Services. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Allergy Diagnostics Market is Predict to reach $11.4 Billion by 2028, at a CAGR of 13.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation, Hitachi chemical Diagnostic Inc., Hycor Biomedical Inc., Lincoln Diagnostics Inc., Omega Diagnostic Llc, Siemens Healthcare Diagnostics, Inc., Thermo Fisher Scientific Inc., Neogen Corporation, Eurofins Scientific Group, and ACON Laboratories, Inc.
By End-user
By Allergen
By Test Type
By Product & Services
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
